US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioVie Inc

1.13

+0.07006.60%

Post-market: 1.11-0.0200-1.77%19:33 EST

Volume:194.74K

Turnover:216.10K

Market Cap:8.45M

PE:-0.13

High:1.18

Open:1.11

Low:1.08

Close:1.06

52wk High:20.30

52wk Low:1.06

Shares:7.48M

Float Shares:7.44M

Volume Ratio:1.44

T/O Rate:2.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.9218

EPS(LYR):-12.1239

ROE:-94.79%

ROA:-50.01%

PB:0.34

PE(LYR):-0.09

Loading ...

Overview Company News Filings

BRIEF-Option Therapeutics Files For IPO Of 2.3 Million Shares Of Common Stock - SEC Filing

Option Therapeutics Inc Says Thinkequity Is the Underwriter to IPO

THOMSON REUTERS

BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies

BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease

BioVie Inc - Topline Results From Sunrise-Pd Trial Expected in 1H 2026

THOMSON REUTERS

BioVie Completes Enrollment in Phase 2 Sunrise-Pd Trial in Early Parkinson’s Disease

THOMSON REUTERS

Halozyme Therapeutics Elects Jim Lang to Board of Directors

Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

BioVie Inc. Files Initial Statement of Beneficial Ownership for Director Kameel D. Farag

BioVie Inc. Files Initial Beneficial Ownership Statement for Director Amy Suzon Chappell

BioVie to Host Live Investor Webinar and Q&A on Oct. 8

BioVie Inc. Announces Date for Upcoming Virtual Annual Stockholders Meeting

BioVie Inc. Reports Net Loss of $17.5 Million for Fiscal Year Ending June 30, 2025; R&D Expenses Drop by $13.8 Million

Cuong V Do, President & CEO of BioVie Inc., Reports Acquisition of Common Shares

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes

BioVie Inc. Announces Closing of $12 Million Public Offering

BRIEF-Biovie Announces Pricing Of $12 Million Public Offering

BioVie Inc - Units Sold at $2.00 Each, Pre-Funded Units Less $0.0001

THOMSON REUTERS

BioVie Inc. Announces Pricing of $12 Million Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BIVI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIVI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIVI\",,,,,undefined,":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":1.13,"timestamp":1770411600000,"preClose":1.06,"halted":0,"volume":194743,"hourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.13,"latestTime":"19:33 EST","volume":341,"amount":378.8202,"timestamp":1770424426215,"change":-0.02,"changeRate":-0.017699,"amplitude":0.017699},"delay":0,"changeRate":0.06603773584905645,"floatShares":7443300,"shares":7477100,"eps":-8.9218,"marketStatus":"Closed","change":0.07,"latestTime":"02-06 16:00:00 EST","open":1.105,"high":1.18,"low":1.08,"amount":216103.8922868,"amplitude":0.09434,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.9218,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":1.0656,"preClose":1.06,"latestTime":"08:35 EST","volume":1079,"amount":1137.0131903000001,"timestamp":1770384952771,"change":0.0056,"changeRate":0.005283,"amplitude":0.169811},"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.13,"latestTime":"19:33 EST","volume":341,"amount":378.8202,"timestamp":1770424426215,"change":-0.02,"changeRate":-0.017699,"amplitude":0.017699},"volumeRatio":1.435948,"impliedVol":1.6378,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIVI\",,,,,undefined,":{"symbol":"BIVI","floatShares":7443300,"roa":"-50.01%","roe":"-94.79%","lyrEps":-12.12395,"volumeRatio":1.435948,"shares":7477100,"dividePrice":0,"high":1.18,"amplitude":0.09434,"preClose":1.06,"low":1.08,"week52Low":1.06,"pbRate":"0.34","week52High":20.3,"institutionHeld":0,"latestPrice":1.13,"eps":-8.9218,"divideRate":0,"volume":194743,"delay":0,"ttmEps":-8.9218,"open":1.105,"prevYearClose":1.16,"prevWeekClose":1.14,"prevMonthClose":1.14,"prevQuarterClose":1.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIVI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"BIVI","fiscalQuarterEnding":"2025/09","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.98},{"market":"US","date":"2025-08-15","symbol":"BIVI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755230400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-07-07","symbol":"BIVI","type":"split","dateTimestamp":1751860800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-05-12","symbol":"BIVI","fiscalQuarterEnding":"2025/03","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2025-02-11","symbol":"BIVI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIVI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIVI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIVI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIVI","date":"2026-02-05","current":-0.126656,"percent":0.913008,"low":-37.883954,"twenty":-5.266135,"median":-1.020049,"eighty":-0.607807,"high":-0.205844,"avg":-3.66615,"sd":5.842213,"marketCap":8743475},"quantilePoints":[{"date":"2021-02-12","current":-34.232489,"twenty":-66.137785,"median":-14.18153,"eighty":-3.247845,"marketCap":521856150},{"date":"2021-02-19","current":-37.883954,"twenty":-66.137785,"median":-14.18153,"eighty":-3.247845,"marketCap":577520806},{"date":"2021-02-26","current":-29.30301,"twenty":-66.137785,"median":-14.18153,"eighty":-3.247845,"marketCap":446708864},{"date":"2021-03-05","current":-13.492165,"twenty":-66.256373,"median":-14.178852,"eighty":-3.247845,"marketCap":205680903},{"date":"2021-03-12","current":-18.622474,"twenty":-66.256373,"median":-14.178852,"eighty":-3.247845,"marketCap":283889745},{"date":"2021-03-19","current":-19.8092,"twenty":-66.256373,"median":-14.178852,"eighty":-3.247845,"marketCap":301980758},{"date":"2021-03-26","current":-16.933671,"twenty":-66.137785,"median":-14.178852,"eighty":-3.247845,"marketCap":258144842},{"date":"2021-04-01","current":-17.061472,"twenty":-66.137785,"median":-14.178852,"eighty":-3.247845,"marketCap":260093105},{"date":"2021-04-09","current":-15.062295,"twenty":-66.256373,"median":-14.178852,"eighty":-3.247845,"marketCap":229616706},{"date":"2021-04-16","current":-12.040707,"twenty":-66.256373,"median":-13.864649,"eighty":-3.247845,"marketCap":183554203},{"date":"2021-04-23","current":-16.221635,"twenty":-66.256373,"median":-13.539984,"eighty":-3.247845,"marketCap":247290234},{"date":"2021-04-30","current":-16.032936,"twenty":-66.256373,"median":-13.539984,"eighty":-3.247845,"marketCap":244413615},{"date":"2021-05-07","current":-14.055144,"twenty":-66.256373,"median":-13.506219,"eighty":-3.247845,"marketCap":214263220},{"date":"2021-05-14","current":-10.281051,"twenty":-66.256373,"median":-13.503669,"eighty":-3.247845,"marketCap":183732010},{"date":"2021-05-21","current":-11.680525,"twenty":-66.256373,"median":-13.503669,"eighty":-3.247845,"marketCap":208741919},{"date":"2021-05-28","current":-10.750149,"twenty":-66.256373,"median":-13.413017,"eighty":-3.247845,"marketCap":192115220},{"date":"2021-06-04","current":-11.727435,"twenty":-66.256373,"median":-13.280478,"eighty":-3.247845,"marketCap":209580240},{"date":"2021-06-11","current":-22.607088,"twenty":-66.256373,"median":-13.214643,"eighty":-3.247845,"marketCap":404009831},{"date":"2021-06-18","current":-20.645058,"twenty":-66.256373,"median":-13.214643,"eighty":-3.247845,"marketCap":368946512},{"date":"2021-06-25","current":-21.669813,"twenty":-65.050759,"median":-13.214643,"eighty":-3.247845,"marketCap":387259838},{"date":"2021-07-02","current":-20.757531,"twenty":-62.000108,"median":-13.214643,"eighty":-3.247845,"marketCap":370956511},{"date":"2021-07-09","current":-18.957962,"twenty":-62.000108,"median":-13.214643,"eighty":-3.247845,"marketCap":338796525},{"date":"2021-07-16","current":-18.183147,"twenty":-62.000108,"median":-13.214643,"eighty":-3.247845,"marketCap":324949864},{"date":"2021-07-23","current":-19.620303,"twenty":-62.000108,"median":-13.214643,"eighty":-3.247845,"marketCap":350633186},{"date":"2021-07-30","current":-17.67077,"twenty":-62.000108,"median":-13.214643,"eighty":-3.247845,"marketCap":315793201},{"date":"2021-08-06","current":-16.058656,"twenty":-62.000108,"median":-13.214643,"eighty":-3.247845,"marketCap":286983213},{"date":"2021-08-13","current":-11.297389,"twenty":-62.000108,"median":-13.006773,"eighty":-3.247845,"marketCap":201894924},{"date":"2021-08-20","current":-10.755448,"twenty":-62.000108,"median":-12.988743,"eighty":-3.247845,"marketCap":192209927},{"date":"2021-08-27","current":-10.977783,"twenty":-62.000108,"median":-12.884483,"eighty":-3.247845,"marketCap":196183259},{"date":"2021-09-03","current":-1.481429,"twenty":-62.000108,"median":-12.830908,"eighty":-3.11417,"marketCap":192954927},{"date":"2021-09-10","current":-1.399445,"twenty":-60.765754,"median":-12.829697,"eighty":-3.08004,"marketCap":182276598},{"date":"2021-09-17","current":-1.433764,"twenty":-54.735883,"median":-12.776148,"eighty":-2.9486,"marketCap":186746596},{"date":"2021-09-24","current":-1.368939,"twenty":-51.656665,"median":-12.476635,"eighty":-2.891729,"marketCap":178303266},{"date":"2021-10-01","current":-1.332714,"twenty":-49.836918,"median":-12.249024,"eighty":-2.719775,"marketCap":173584934},{"date":"2021-10-08","current":-1.094389,"twenty":-45.978142,"median":-12.131639,"eighty":-2.706537,"marketCap":142543279},{"date":"2021-10-15","current":-1.124894,"twenty":-45.873853,"median":-11.906213,"eighty":-2.669289,"marketCap":146516611},{"date":"2021-10-22","current":-1.067696,"twenty":-44.79097,"median":-11.715539,"eighty":-2.607765,"marketCap":139066614},{"date":"2021-10-29","current":-1.16684,"twenty":-43.788708,"median":-11.631718,"eighty":-2.5684,"marketCap":151979942},{"date":"2021-11-05","current":-1.254543,"twenty":-43.788708,"median":-11.443561,"eighty":-2.499021,"marketCap":163403271},{"date":"2021-11-12","current":-1.084836,"twenty":-43.689384,"median":-11.283494,"eighty":-2.447724,"marketCap":155265960},{"date":"2021-11-19","current":-1.030769,"twenty":-43.689384,"median":-11.1997,"eighty":-2.240482,"marketCap":147527624},{"date":"2021-11-26","current":-1.070883,"twenty":-42.86709,"median":-11.011733,"eighty":-2.17866,"marketCap":153268970},{"date":"2021-12-03","current":-0.931355,"twenty":-40.682803,"median":-10.934081,"eighty":-2.065216,"marketCap":133299071},{"date":"2021-12-10","current":-0.92089,"twenty":-39.165497,"median":-10.851155,"eighty":-1.996799,"marketCap":131801329},{"date":"2021-12-17","current":-0.858102,"twenty":-37.757979,"median":-10.78324,"eighty":-1.867675,"marketCap":122814875},{"date":"2021-12-23","current":-0.873799,"twenty":-36.536223,"median":-10.711057,"eighty":-1.69717,"marketCap":125061488},{"date":"2021-12-31","current":-0.784849,"twenty":-34.236141,"median":-10.603176,"eighty":-1.633994,"marketCap":112330678},{"date":"2022-01-07","current":-0.851126,"twenty":-32.831564,"median":-10.225499,"eighty":-1.629657,"marketCap":121816380},{"date":"2022-01-14","current":-0.779617,"twenty":-30.768832,"median":-9.583938,"eighty":-1.522993,"marketCap":111581807},{"date":"2022-01-21","current":-0.6959,"twenty":-30.214124,"median":-9.583938,"eighty":-1.481048,"marketCap":99599868},{"date":"2022-01-28","current":-0.502304,"twenty":-28.175552,"median":-9.583938,"eighty":-1.458549,"marketCap":71891634},{"date":"2022-02-04","current":-0.47963,"twenty":-27.260556,"median":-9.393747,"eighty":-1.439865,"marketCap":68646525},{"date":"2022-02-11","current":-0.53753,"twenty":-25.959777,"median":-9.064866,"eighty":-1.391441,"marketCap":78200117},{"date":"2022-02-18","current":-0.542682,"twenty":-24.376364,"median":-8.787135,"eighty":-1.344916,"marketCap":78949639},{"date":"2022-02-25","current":-0.563291,"twenty":-23.852991,"median":-8.577679,"eighty":-1.286647,"marketCap":81947726},{"date":"2022-03-04","current":-0.534096,"twenty":-23.384828,"median":-8.242387,"eighty":-1.273609,"marketCap":77700435},{"date":"2022-03-11","current":-0.552986,"twenty":-22.629096,"median":-8.117211,"eighty":-1.235148,"marketCap":80448682},{"date":"2022-03-18","current":-0.685222,"twenty":-22.25931,"median":-8.077497,"eighty":-1.203199,"marketCap":99686411},{"date":"2022-03-25","current":-0.697244,"twenty":-21.755889,"median":-7.942343,"eighty":-1.196173,"marketCap":101435295},{"date":"2022-04-01","current":-0.850088,"twenty":-21.64766,"median":-7.826833,"eighty":-1.147424,"marketCap":123671111},{"date":"2022-04-08","current":-0.839784,"twenty":-21.512512,"median":-7.78757,"eighty":-1.12494,"marketCap":122172068},{"date":"2022-04-14","current":-0.759068,"twenty":-21.251189,"median":-7.74684,"eighty":-1.102225,"marketCap":110429558},{"date":"2022-04-22","current":-0.673201,"twenty":-21.172431,"median":-7.649088,"eighty":-1.083696,"marketCap":97937526},{"date":"2022-04-29","current":-0.638854,"twenty":-20.946276,"median":-7.587993,"eighty":-1.070246,"marketCap":92940714},{"date":"2022-05-06","current":-0.566725,"twenty":-20.770184,"median":-7.489785,"eighty":-1.052076,"marketCap":82447407},{"date":"2022-05-13","current":-0.437766,"twenty":-20.565277,"median":-7.446936,"eighty":-1.030071,"marketCap":65458297},{"date":"2022-05-20","current":-0.477866,"twenty":-20.546419,"median":-7.255693,"eighty":-0.974259,"marketCap":71454477},{"date":"2022-05-27","current":-0.441107,"twenty":-20.273311,"median":-7.186613,"eighty":-0.919495,"marketCap":65957979},{"date":"2022-06-03","current":-0.330831,"twenty":-19.933128,"median":-7.133026,"eighty":-0.904495,"marketCap":49468484},{"date":"2022-06-10","current":-0.292401,"twenty":-19.809275,"median":-6.919601,"eighty":-0.866566,"marketCap":43722145},{"date":"2022-06-17","current":-0.285717,"twenty":-19.694495,"median":-6.848066,"eighty":-0.851126,"marketCap":42722781},{"date":"2022-06-24","current":-0.297413,"twenty":-19.559696,"median":-6.683787,"eighty":-0.847542,"marketCap":44471667},{"date":"2022-07-01","current":-0.230579,"twenty":-19.482894,"median":-6.553562,"eighty":-0.837723,"marketCap":34478034},{"date":"2022-07-08","current":-0.300755,"twenty":-19.421713,"median":-6.527926,"eighty":-0.82734,"marketCap":44971349},{"date":"2022-07-15","current":-0.297995,"twenty":-19.264364,"median":-6.527926,"eighty":-0.804732,"marketCap":44558618},{"date":"2022-07-22","current":-0.367915,"twenty":-18.793002,"median":-6.492357,"eighty":-0.791128,"marketCap":55013713},{"date":"2022-07-29","current":-0.357927,"twenty":-18.513145,"median":-6.341351,"eighty":-0.766043,"marketCap":53520128},{"date":"2022-08-05","current":-0.362921,"twenty":-18.287155,"median":-6.266809,"eighty":-0.743612,"marketCap":54266920},{"date":"2022-08-12","current":-0.371245,"twenty":-18.116335,"median":-6.225884,"eighty":-0.719081,"marketCap":55511575},{"date":"2022-08-19","current":-0.522782,"twenty":-17.815182,"median":-5.929413,"eighty":-0.69575,"marketCap":78170684},{"date":"2022-08-26","current":-0.511182,"twenty":-17.638559,"median":-5.882602,"eighty":-0.686253,"marketCap":76436094},{"date":"2022-09-02","current":-0.537848,"twenty":-17.326787,"median":-5.779576,"eighty":-0.676782,"marketCap":80423456},{"date":"2022-09-09","current":-0.537848,"twenty":-17.230161,"median":-5.777483,"eighty":-0.661606,"marketCap":80423456},{"date":"2022-09-16","current":-0.497653,"twenty":-17.134515,"median":-5.671884,"eighty":-0.627988,"marketCap":74413162},{"date":"2022-09-23","current":-0.417263,"twenty":-16.494623,"median":-5.614016,"eighty":-0.607878,"marketCap":62392574},{"date":"2022-09-30","current":-2.879554,"twenty":-16.227279,"median":-5.577291,"eighty":-0.601232,"marketCap":75111644},{"date":"2022-10-07","current":-3.099279,"twenty":-16.019883,"median":-5.466307,"eighty":-0.601232,"marketCap":80843054},{"date":"2022-10-14","current":-3.029893,"twenty":-15.904764,"median":-5.350834,"eighty":-0.601232,"marketCap":79033135},{"date":"2022-10-21","current":-3.931922,"twenty":-15.850937,"median":-5.149227,"eighty":-0.601232,"marketCap":102562084},{"date":"2022-10-28","current":-4.544839,"twenty":-15.654651,"median":-5.106681,"eighty":-0.601232,"marketCap":118549703},{"date":"2022-11-04","current":-4.122403,"twenty":-15.244598,"median":-4.998794,"eighty":-0.601232,"marketCap":127627229},{"date":"2022-11-11","current":-5.000139,"twenty":-15.153362,"median":-4.899568,"eighty":-0.601232,"marketCap":154801448},{"date":"2022-11-18","current":-5.591872,"twenty":-15.072745,"median":-4.893696,"eighty":-0.601232,"marketCap":173121146},{"date":"2022-11-25","current":-6.51892,"twenty":-14.853016,"median":-4.893696,"eighty":-0.601232,"marketCap":201822006},{"date":"2022-12-02","current":-5.414352,"twenty":-14.514233,"median":-4.893696,"eighty":-0.601232,"marketCap":167625236},{"date":"2022-12-09","current":-8.284871,"twenty":-14.324767,"median":-4.893696,"eighty":-0.601232,"marketCap":256494837},{"date":"2022-12-16","current":-14.036034,"twenty":-14.148578,"median":-4.893696,"eighty":-0.601232,"marketCap":434547571},{"date":"2022-12-23","current":-6.724289,"twenty":-13.981516,"median":-4.893696,"eighty":-0.601232,"marketCap":208180114},{"date":"2022-12-30","current":-8.150971,"twenty":-13.634848,"median":-4.893696,"eighty":-0.601232,"marketCap":252349374},{"date":"2023-01-06","current":-6.315166,"twenty":-13.634848,"median":-4.893696,"eighty":-0.601232,"marketCap":195513929},{"date":"2023-01-13","current":-5.76967,"twenty":-13.634848,"median":-4.893696,"eighty":-0.601232,"marketCap":178625683},{"date":"2023-01-20","current":-5.192703,"twenty":-13.634848,"median":-4.893696,"eighty":-0.601232,"marketCap":160763115},{"date":"2023-01-27","current":-5.297606,"twenty":-13.634848,"median":-4.893696,"eighty":-0.601232,"marketCap":164010854},{"date":"2023-02-03","current":-5.675258,"twenty":-13.634848,"median":-4.901517,"eighty":-0.601232,"marketCap":175702717},{"date":"2023-02-10","current":-4.183359,"twenty":-13.634848,"median":-4.962831,"eighty":-0.601232,"marketCap":172488710},{"date":"2023-02-17","current":-4.904627,"twenty":-13.634848,"median":-4.962831,"eighty":-0.601232,"marketCap":202228143},{"date":"2023-02-24","current":-5.345874,"twenty":-13.634848,"median":-4.998794,"eighty":-0.601232,"marketCap":220421678},{"date":"2023-03-03","current":-5.829549,"twenty":-13.634848,"median":-5.034756,"eighty":-0.601232,"marketCap":240364592},{"date":"2023-03-10","current":-6.915694,"twenty":-13.634848,"median":-5.116137,"eighty":-0.601232,"marketCap":285148679},{"date":"2023-03-17","current":-8.392174,"twenty":-13.634848,"median":-5.149836,"eighty":-0.601232,"marketCap":346027047},{"date":"2023-03-24","current":-6.92418,"twenty":-13.634848,"median":-5.245155,"eighty":-0.601232,"marketCap":285498554},{"date":"2023-03-31","current":-6.856296,"twenty":-13.604299,"median":-5.297606,"eighty":-0.603219,"marketCap":282699549},{"date":"2023-04-06","current":-5.897433,"twenty":-13.604299,"median":-5.348354,"eighty":-0.603219,"marketCap":243163597},{"date":"2023-04-14","current":-6.669614,"twenty":-13.634848,"median":-5.392019,"eighty":-0.601232,"marketCap":275002284},{"date":"2023-04-21","current":-6.919799,"twenty":-13.634848,"median":-5.461302,"eighty":-0.601232,"marketCap":285317923},{"date":"2023-04-28","current":-6.569872,"twenty":-13.634848,"median":-5.564868,"eighty":-0.601232,"marketCap":270889710},{"date":"2023-05-05","current":-6.43865,"twenty":-13.634848,"median":-5.591872,"eighty":-0.601232,"marketCap":265479130},{"date":"2023-05-12","current":-6.814821,"twenty":-13.634848,"median":-5.614016,"eighty":-0.601232,"marketCap":280989459},{"date":"2023-05-19","current":-5.179871,"twenty":-13.634848,"median":-5.614016,"eighty":-0.601232,"marketCap":255018675},{"date":"2023-05-26","current":-4.701553,"twenty":-13.634848,"median":-5.614016,"eighty":-0.607878,"marketCap":231469851},{"date":"2023-06-02","current":-4.436262,"twenty":-13.634848,"median":-5.614016,"eighty":-0.607878,"marketCap":218408856},{"date":"2023-06-09","current":-4.17834,"twenty":-13.634848,"median":-5.614016,"eighty":-0.607878,"marketCap":205710667},{"date":"2023-06-16","current":-4.259401,"twenty":-13.634848,"median":-5.614016,"eighty":-0.607878,"marketCap":209701526},{"date":"2023-06-23","current":-4.303616,"twenty":-13.665396,"median":-5.615678,"eighty":-0.606987,"marketCap":211878359},{"date":"2023-06-30","current":-3.01769,"twenty":-13.695945,"median":-5.617339,"eighty":-0.606097,"marketCap":148568815},{"date":"2023-07-07","current":-3.264558,"twenty":-13.695945,"median":-5.617339,"eighty":-0.606097,"marketCap":160722796},{"date":"2023-07-14","current":-3.662495,"twenty":-13.726494,"median":-5.617339,"eighty":-0.605206,"marketCap":180314288},{"date":"2023-07-21","current":-3.721449,"twenty":-13.726494,"median":-5.617339,"eighty":-0.605206,"marketCap":183216732},{"date":"2023-07-28","current":-3.397204,"twenty":-13.726494,"median":-5.617339,"eighty":-0.605206,"marketCap":167253294},{"date":"2023-08-04","current":-3.080328,"twenty":-13.726494,"median":-5.610157,"eighty":-0.605206,"marketCap":151652661},{"date":"2023-08-11","current":-2.697129,"twenty":-13.726494,"median":-5.601014,"eighty":-0.605206,"marketCap":132786780},{"date":"2023-08-18","current":-2.612788,"twenty":-13.506219,"median":-5.53171,"eighty":-0.605206,"marketCap":131307770},{"date":"2023-08-25","current":-2.533857,"twenty":-13.506219,"median":-5.463454,"eighty":-0.605206,"marketCap":127341037},{"date":"2023-09-01","current":-2.277542,"twenty":-13.506219,"median":-5.406604,"eighty":-0.605206,"marketCap":114459718},{"date":"2023-09-08","current":-2.394714,"twenty":-13.506219,"median":-5.365793,"eighty":-0.605206,"marketCap":120348321},{"date":"2023-09-15","current":-2.533857,"twenty":-13.506219,"median":-5.297606,"eighty":-0.605206,"marketCap":127341037},{"date":"2023-09-22","current":-2.013904,"twenty":-13.506219,"median":-5.245155,"eighty":-0.605206,"marketCap":101210362},{"date":"2023-09-29","current":-2.321481,"twenty":-13.506219,"median":-5.186287,"eighty":-0.605206,"marketCap":116667944},{"date":"2023-10-06","current":-2.738909,"twenty":-13.506219,"median":-5.133985,"eighty":-0.605206,"marketCap":137646092},{"date":"2023-10-13","current":-2.54118,"twenty":-13.506219,"median":-5.116137,"eighty":-0.605206,"marketCap":127709074},{"date":"2023-10-20","current":-2.486255,"twenty":-13.506219,"median":-5.032958,"eighty":-0.605206,"marketCap":124948792},{"date":"2023-10-27","current":-2.365421,"twenty":-13.506219,"median":-4.998794,"eighty":-0.599244,"marketCap":118876170},{"date":"2023-11-03","current":-3.280832,"twenty":-13.506219,"median":-4.959476,"eighty":-0.599244,"marketCap":164880880},{"date":"2023-11-10","current":-2.191456,"twenty":-13.506219,"median":-4.893696,"eighty":-0.599244,"marketCap":110779341},{"date":"2023-11-17","current":-2.880254,"twenty":-13.506219,"median":-4.891773,"eighty":-0.599244,"marketCap":145598485},{"date":"2023-11-24","current":-3.719707,"twenty":-13.506219,"median":-4.862069,"eighty":-0.599244,"marketCap":188033277},{"date":"2023-12-01","current":-1.343124,"twenty":-13.506219,"median":-4.775826,"eighty":-0.599244,"marketCap":67895667},{"date":"2023-12-08","current":-1.298353,"twenty":-13.506219,"median":-4.736744,"eighty":-0.601232,"marketCap":65632478},{"date":"2023-12-15","current":-1.104346,"twenty":-13.506219,"median":-4.678318,"eighty":-0.601232,"marketCap":55825326},{"date":"2023-12-22","current":-0.925263,"twenty":-13.506219,"median":-4.605552,"eighty":-0.601232,"marketCap":46772570},{"date":"2023-12-29","current":-0.906609,"twenty":-13.506219,"median":-4.594763,"eighty":-0.599244,"marketCap":45829575},{"date":"2024-01-05","current":-0.932725,"twenty":-13.506219,"median":-4.531081,"eighty":-0.597257,"marketCap":47149768},{"date":"2024-01-12","current":-0.917801,"twenty":-13.506219,"median":-4.442059,"eighty":-0.597257,"marketCap":46395372},{"date":"2024-01-19","current":-0.925263,"twenty":-13.506219,"median":-4.436262,"eighty":-0.59527,"marketCap":46772570},{"date":"2024-01-26","current":-0.74245,"twenty":-13.506219,"median":-4.414155,"eighty":-0.597257,"marketCap":37531249},{"date":"2024-02-02","current":-0.843371,"twenty":-13.506219,"median":-4.414155,"eighty":-0.597257,"marketCap":42632902},{"date":"2024-02-09","current":-0.867017,"twenty":-13.506219,"median":-4.341257,"eighty":-0.597257,"marketCap":43828217},{"date":"2024-02-16","current":-1.086811,"twenty":-13.506219,"median":-4.294958,"eighty":-0.597257,"marketCap":47020897},{"date":"2024-02-23","current":-1.151283,"twenty":-13.506219,"median":-4.22138,"eighty":-0.597257,"marketCap":49810272},{"date":"2024-03-01","current":-1.142073,"twenty":-13.506219,"median":-4.122403,"eighty":-0.599244,"marketCap":49411790},{"date":"2024-03-08","current":-0.945632,"twenty":-13.506219,"median":-4.060432,"eighty":-0.599244,"marketCap":40912758},{"date":"2024-03-15","current":-0.844368,"twenty":-13.506219,"median":-4.003933,"eighty":-0.599244,"marketCap":36531601},{"date":"2024-03-22","current":-0.720137,"twenty":-13.506219,"median":-4.003933,"eighty":-0.599244,"marketCap":31156723},{"date":"2024-03-28","current":-0.677119,"twenty":-13.503669,"median":-3.870469,"eighty":-0.599244,"marketCap":29295555},{"date":"2024-04-05","current":-0.623315,"twenty":-13.503669,"median":-3.781492,"eighty":-0.597257,"marketCap":26967722},{"date":"2024-04-12","current":-0.628518,"twenty":-13.503669,"median":-3.720578,"eighty":-0.591493,"marketCap":27192819},{"date":"2024-04-19","current":-0.619762,"twenty":-13.503669,"median":-3.65971,"eighty":-0.591493,"marketCap":26813998},{"date":"2024-04-26","current":-0.620396,"twenty":-13.503669,"median":-3.559326,"eighty":-0.591518,"marketCap":26841448},{"date":"2024-05-03","current":-0.634355,"twenty":-13.418136,"median":-3.507742,"eighty":-0.591518,"marketCap":27445367},{"date":"2024-05-10","current":-0.631182,"twenty":-13.341587,"median":-3.368711,"eighty":-0.591518,"marketCap":27308113},{"date":"2024-05-17","current":-0.83815,"twenty":-13.25397,"median":-3.280832,"eighty":-0.591518,"marketCap":30417856},{"date":"2024-05-24","current":-0.772798,"twenty":-13.172615,"median":-3.235081,"eighty":-0.591518,"marketCap":28046129},{"date":"2024-05-31","current":-0.739198,"twenty":-12.988772,"median":-3.122408,"eighty":-0.591518,"marketCap":26826732},{"date":"2024-06-07","current":-0.79447,"twenty":-12.978238,"median":-3.11417,"eighty":-0.591518,"marketCap":28832640},{"date":"2024-06-14","current":-0.816814,"twenty":-12.830908,"median":-3.093497,"eighty":-0.591493,"marketCap":29643539},{"date":"2024-06-21","current":-0.781396,"twenty":-12.830908,"median":-3.041457,"eighty":-0.591469,"marketCap":28358177},{"date":"2024-06-28","current":-0.751252,"twenty":-12.723811,"median":-3.019859,"eighty":-0.591048,"marketCap":27264187},{"date":"2024-07-05","current":-0.700225,"twenty":-12.230583,"median":-2.970541,"eighty":-0.591048,"marketCap":25412349},{"date":"2024-07-12","current":-0.73458,"twenty":-12.068188,"median":-2.900615,"eighty":-0.591048,"marketCap":26659131},{"date":"2024-07-15","current":-0.781059,"twenty":-11.995853,"median":-2.896166,"eighty":-0.591048,"marketCap":28345953},{"date":"2024-08-02","current":-0.640442,"twenty":-11.435031,"median":-2.879554,"eighty":-0.584551,"marketCap":23242704},{"date":"2024-08-09","current":-0.415959,"twenty":-11.266619,"median":-2.826788,"eighty":-0.572287,"marketCap":15095839},{"date":"2024-08-16","current":-0.399118,"twenty":-11.175455,"median":-2.733975,"eighty":-0.564665,"marketCap":14484672},{"date":"2024-08-23","current":-0.56247,"twenty":-10.963887,"median":-2.687646,"eighty":-0.56247,"marketCap":20412997},{"date":"2024-08-30","current":-0.46648,"twenty":-10.835989,"median":-2.669289,"eighty":-0.552986,"marketCap":16929342},{"date":"2024-09-06","current":-0.442903,"twenty":-10.757515,"median":-2.660391,"eighty":-0.551269,"marketCap":16073707},{"date":"2024-09-13","current":-0.533842,"twenty":-10.659368,"median":-2.60709,"eighty":-0.543911,"marketCap":19374012},{"date":"2024-09-20","current":-0.493296,"twenty":-10.30607,"median":-2.548503,"eighty":-0.537784,"marketCap":17902534},{"date":"2024-09-27","current":-0.253605,"twenty":-9.564465,"median":-2.533857,"eighty":-0.534045,"marketCap":9203742},{"date":"2024-10-04","current":-0.291334,"twenty":-8.432544,"median":-2.504564,"eighty":-0.523792,"marketCap":9357794},{"date":"2024-10-11","current":-0.288865,"twenty":-8.174771,"median":-2.491336,"eighty":-0.513148,"marketCap":9278490},{"date":"2024-10-18","current":-0.27652,"twenty":-7.93973,"median":-2.438654,"eighty":-0.497955,"marketCap":8881974},{"date":"2024-10-25","current":-0.66908,"twenty":-7.796945,"median":-2.365421,"eighty":-0.497955,"marketCap":21491205},{"date":"2024-10-31","current":-0.802502,"twenty":-7.750098,"median":-2.335543,"eighty":-0.497955,"marketCap":25776788},{"date":"2024-11-08","current":-0.748813,"twenty":-7.636054,"median":-2.270218,"eighty":-0.49788,"marketCap":24052285},{"date":"2024-11-15","current":-1.129122,"twenty":-7.579032,"median":-2.054182,"eighty":-0.49788,"marketCap":28862742},{"date":"2024-11-22","current":-1.104268,"twenty":-7.518108,"median":-1.52242,"eighty":-0.49788,"marketCap":28227398},{"date":"2024-11-29","current":-1.943392,"twenty":-7.518108,"median":-1.52242,"eighty":-0.49788,"marketCap":49677174},{"date":"2024-12-06","current":-2.047502,"twenty":-7.518108,"median":-1.52242,"eighty":-0.49788,"marketCap":52338451},{"date":"2024-12-13","current":-1.797637,"twenty":-7.518108,"median":-1.52242,"eighty":-0.49788,"marketCap":45951386},{"date":"2024-12-20","current":-1.443662,"twenty":-7.518108,"median":-1.501448,"eighty":-0.49788,"marketCap":36903043},{"date":"2024-12-27","current":-1.561654,"twenty":-7.518108,"median":-1.483335,"eighty":-0.49788,"marketCap":39919158},{"date":"2025-01-03","current":-1.513069,"twenty":-7.518108,"median":-1.477038,"eighty":-0.49788,"marketCap":38677228},{"date":"2025-01-10","current":-1.638002,"twenty":-7.53227,"median":-1.475709,"eighty":-0.497804,"marketCap":41870761},{"date":"2025-01-17","current":-1.547773,"twenty":-7.53227,"median":-1.471425,"eighty":-0.497804,"marketCap":39564321},{"date":"2025-01-24","current":-1.346493,"twenty":-7.53227,"median":-1.460456,"eighty":-0.497804,"marketCap":34419185},{"date":"2025-01-31","current":-1.159094,"twenty":-7.53227,"median":-1.443662,"eighty":-0.497804,"marketCap":29628886},{"date":"2025-02-07","current":-1.367315,"twenty":-7.53227,"median":-1.407071,"eighty":-0.497804,"marketCap":34951440},{"date":"2025-02-14","current":-1.345518,"twenty":-7.53227,"median":-1.388137,"eighty":-0.49974,"marketCap":32660006},{"date":"2025-02-21","current":-1.239093,"twenty":-7.53227,"median":-1.391129,"eighty":-0.512165,"marketCap":30076729},{"date":"2025-02-28","current":-1.003437,"twenty":-7.53227,"median":-1.391129,"eighty":-0.523792,"marketCap":24356614},{"date":"2025-03-07","current":-0.912216,"twenty":-7.546431,"median":-1.393104,"eighty":-0.534096,"marketCap":22142377},{"date":"2025-03-14","current":-0.775383,"twenty":-7.546431,"median":-1.393104,"eighty":-0.537848,"marketCap":18821020},{"date":"2025-03-21","current":-0.874207,"twenty":-7.546431,"median":-1.393104,"eighty":-0.543989,"marketCap":21219778},{"date":"2025-03-28","current":-0.820994,"twenty":-7.546431,"median":-1.393104,"eighty":-0.551296,"marketCap":19928139},{"date":"2025-04-04","current":-0.666906,"twenty":-7.546431,"median":-1.393104,"eighty":-0.555459,"marketCap":16187922},{"date":"2025-04-11","current":-0.563065,"twenty":-7.53227,"median":-1.391129,"eighty":-0.56247,"marketCap":13667382},{"date":"2025-04-17","current":-0.602974,"twenty":-7.53227,"median":-1.391129,"eighty":-0.563978,"marketCap":14636111},{"date":"2025-04-25","current":-0.679715,"twenty":-7.546431,"median":-1.393104,"eighty":-0.57263,"marketCap":16498838},{"date":"2025-05-02","current":-0.655275,"twenty":-7.546431,"median":-1.393104,"eighty":-0.581298,"marketCap":15905607},{"date":"2025-05-09","current":-0.935021,"twenty":-7.546431,"median":-1.393104,"eighty":-0.591493,"marketCap":22695936},{"date":"2025-05-16","current":-1.020049,"twenty":-7.546431,"median":-1.393104,"eighty":-0.599116,"marketCap":19374580},{"date":"2025-05-23","current":-1.00062,"twenty":-7.546431,"median":-1.393104,"eighty":-0.606573,"marketCap":19005540},{"date":"2025-05-30","current":-1.029764,"twenty":-7.546431,"median":-1.393104,"eighty":-0.610714,"marketCap":19559099},{"date":"2025-06-06","current":-1.063616,"twenty":-7.546431,"median":-1.393104,"eighty":-0.61532,"marketCap":20202078},{"date":"2025-06-13","current":-1.161195,"twenty":-7.546431,"median":-1.393104,"eighty":-0.618321,"marketCap":22055480},{"date":"2025-06-20","current":-1.064095,"twenty":-7.560593,"median":-1.395078,"eighty":-0.621599,"marketCap":20211180},{"date":"2025-06-27","current":-1.005521,"twenty":-7.560593,"median":-1.395078,"eighty":-0.624076,"marketCap":19098638},{"date":"2025-07-03","current":-0.937185,"twenty":-7.560593,"median":-1.395078,"eighty":-0.628137,"marketCap":17800672},{"date":"2025-07-11","current":-0.739009,"twenty":-7.560593,"median":-1.395078,"eighty":-0.632046,"marketCap":14036574},{"date":"2025-07-18","current":-0.785868,"twenty":-7.560593,"median":-1.395078,"eighty":-0.638551,"marketCap":14926607},{"date":"2025-07-25","current":-0.737057,"twenty":-7.560593,"median":-1.395078,"eighty":-0.641334,"marketCap":13999489},{"date":"2025-08-01","current":-0.586229,"twenty":-7.560593,"median":-1.395078,"eighty":-0.649329,"marketCap":11134693},{"date":"2025-08-08","current":-0.284084,"twenty":-7.560593,"median":-1.388137,"eighty":-0.646305,"marketCap":5395829},{"date":"2025-08-15","current":-0.653226,"twenty":-7.560593,"median":-1.35312,"eighty":-0.646305,"marketCap":12407233},{"date":"2025-08-22","current":-0.65283,"twenty":-7.489785,"median":-1.343124,"eighty":-0.646305,"marketCap":11452022},{"date":"2025-08-29","current":-0.63565,"twenty":-7.46173,"median":-1.320738,"eighty":-0.646267,"marketCap":11150653},{"date":"2025-09-05","current":-0.682894,"twenty":-7.464174,"median":-1.29913,"eighty":-0.64528,"marketCap":11979417},{"date":"2025-09-12","current":-0.807448,"twenty":-7.46173,"median":-1.286956,"eighty":-0.646267,"marketCap":14164343},{"date":"2025-09-19","current":-0.803153,"twenty":-7.421,"median":-1.265983,"eighty":-0.646267,"marketCap":14089000},{"date":"2025-09-26","current":-0.773088,"twenty":-7.252229,"median":-1.246296,"eighty":-0.646267,"marketCap":13561605},{"date":"2025-10-03","current":-0.858987,"twenty":-7.138503,"median":-1.235442,"eighty":-0.646267,"marketCap":15068450},{"date":"2025-10-10","current":-0.837607,"twenty":-6.989784,"median":-1.200738,"eighty":-0.646267,"marketCap":14693406},{"date":"2025-10-17","current":-0.794906,"twenty":-6.919799,"median":-1.161195,"eighty":-0.646267,"marketCap":13944338},{"date":"2025-10-24","current":-0.812093,"twenty":-6.856296,"median":-1.151112,"eighty":-0.646267,"marketCap":14245837},{"date":"2025-10-31","current":-0.760532,"twenty":-6.856296,"median":-1.140147,"eighty":-0.646267,"marketCap":13341339},{"date":"2025-11-07","current":-0.644518,"twenty":-6.814821,"median":-1.132673,"eighty":-0.644518,"marketCap":11306220},{"date":"2025-11-14","current":-0.607807,"twenty":-6.647128,"median":-1.123207,"eighty":-0.639159,"marketCap":11230845},{"date":"2025-11-21","current":-0.518064,"twenty":-6.51892,"median":-1.104268,"eighty":-0.638344,"marketCap":9572598},{"date":"2025-11-28","current":-0.611886,"twenty":-6.406564,"median":-1.096021,"eighty":-0.634355,"marketCap":11306218},{"date":"2025-12-05","current":-0.656758,"twenty":-6.315166,"median":-1.086811,"eighty":-0.630294,"marketCap":12135341},{"date":"2025-12-12","current":-0.615966,"twenty":-6.194426,"median":-1.083132,"eighty":-0.629505,"marketCap":11381593},{"date":"2025-12-19","current":-0.59149,"twenty":-6.132464,"median":-1.074372,"eighty":-0.624183,"marketCap":10929344},{"date":"2025-12-26","current":-0.518064,"twenty":-5.968986,"median":-1.068623,"eighty":-0.6223,"marketCap":9572598},{"date":"2026-01-02","current":-0.473192,"twenty":-5.838427,"median":-1.064095,"eighty":-0.619762,"marketCap":8743475},{"date":"2026-01-09","current":-0.530301,"twenty":-5.633296,"median":-1.055186,"eighty":-0.617224,"marketCap":9798722},{"date":"2026-01-16","current":-0.481351,"twenty":-5.465606,"median":-1.0441,"eighty":-0.615193,"marketCap":8894225},{"date":"2026-01-23","current":-0.509905,"twenty":-5.371039,"median":-1.039479,"eighty":-0.612275,"marketCap":9421848},{"date":"2026-01-30","current":-0.505826,"twenty":-5.318587,"median":-1.029764,"eighty":-0.610549,"marketCap":9346473},{"date":"2026-02-05","current":-0.473192,"twenty":-5.266135,"median":-1.020049,"eighty":-0.607807,"marketCap":8743475}],"updateTime":1770433947134},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIVI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606211055","title":"BRIEF-Option Therapeutics Files For IPO Of 2.3 Million Shares Of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2606211055","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606211055?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:06","pubTimestamp":1769425612,"startTime":"0","endTime":"0","summary":"BRIEF-Option Therapeutics Files For IPO Of 2.3 Million Shares Of Common Stock - SEC FilingJan 26  - BioVie Inc BIVI.O:OPTION THERAPEUTICS INC - FILES FOR IPO OF 2.3 MILLION SHARES OF COMMON STOCK  - SEC FILINGOPTION THERAPEUTICS INC - IPO PRICE EXPECTED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILINGOPTION THERAPEUTICS INC - INTENDS TO LIST ON NYSE AMERICAN UNDER SYMBOL \"OPTN\" - SEC FILINGOPTION THERAPEUTICS INC SAYS THINKEQUITY IS THE UNDERWRITER TO IPOSource text: [ID:n0001520138-26-000041]Further company coverage: BIVI.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YO1GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2606117942","title":"Option Therapeutics Inc Says Thinkequity Is the Underwriter to IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2606117942","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606117942?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:03","pubTimestamp":1769425436,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YO1GI:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2602977535","title":"BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2602977535","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602977535?lang=en_us&edition=fundamental","pubTime":"2026-01-11 02:53","pubTimestamp":1768071205,"startTime":"0","endTime":"0","summary":"BioVie Inc. has released a corporate presentation detailing updates on its lead asset, bezisterim , a small molecule targeting TNF-α-mediated inflammation. Clinical trials have shown that bezisterim may reduce inflammation and insulin resistance, improve motor control in Parkinson’s disease patients, and support cognitive function in Alzheimer’s disease. The company is prioritizing the completion of a Phase 2b trial for Parkinson’s disease with topline data expected in the second quarter of 2026, and a Phase 2 exploratory trial for Long Covid, with topline readout anticipated in summer 2026. BioVie also highlighted plans for a Phase 3 ascites trial and a new Phase 3 Alzheimer’s trial, pending additional funding. Bezisterim has demonstrated the ability to cross the blood-brain barrier and has not shown safety issues in pre-clinical and Phase 2 trials. You can access the full presentation through the link below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260110:nNDL7vWGc4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2601364500","title":"BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364500","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364500?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:02","pubTimestamp":1767877378,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLWMC6y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","BIVI","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4588","BK4139","NDAQ"],"gpt_icon":0},{"id":"2601378364","title":"BioVie Inc - Topline Results From Sunrise-Pd Trial Expected in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601378364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601378364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA3YXWFN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2601364892","title":"BioVie Completes Enrollment in Phase 2 Sunrise-Pd Trial in Early Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364892?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA3YXWFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2590937365","title":"Halozyme Therapeutics Elects Jim Lang to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590937365","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590937365?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:05","pubTimestamp":1765227935,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics Inc. has announced the election of Jim Lang to its Board of Directors. Lang brings over 30 years of executive experience in healthcare, life sciences, business services, and data analytics. He currently serves on the boards of Biovie, Inc., OptimizeRx Corporation, and EVERSANA, where he was most recently CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLbYFWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX","BK4139","LU0053671581.USD","HALO","BK4167","BIVI"],"gpt_icon":0},{"id":"2584949069","title":"Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9","url":"https://stock-news.laohu8.com/highlight/detail?id=2584949069","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584949069?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:00","pubTimestamp":1763557200,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Nov.  19, 2025  (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurod","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190852/0/en/Join-Biovie-s-Exclusive-Live-Investor-Webinar-and-Q-A-Session-on-December-9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2578969532","title":"BioVie Inc. Files Initial Statement of Beneficial Ownership for Director Kameel D. Farag","url":"https://stock-news.laohu8.com/highlight/detail?id=2578969532","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578969532?lang=en_us&edition=fundamental","pubTime":"2025-10-28 23:20","pubTimestamp":1761664851,"startTime":"0","endTime":"0","summary":"BioVie Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names Kameel D. Farag as the beneficial owner, who serves as a Director at BioVie Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 28, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL46VbNs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2578726456","title":"BioVie Inc. Files Initial Beneficial Ownership Statement for Director Amy Suzon Chappell","url":"https://stock-news.laohu8.com/highlight/detail?id=2578726456","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578726456?lang=en_us&edition=fundamental","pubTime":"2025-10-28 06:36","pubTimestamp":1761604565,"startTime":"0","endTime":"0","summary":"BioVie Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Amy Suzon Chappell as the beneficial owner in her capacity as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 27, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nNDL4Bvd50:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2570836348","title":"BioVie to Host Live Investor Webinar and Q&A on Oct. 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2570836348","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570836348?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:00","pubTimestamp":1758888000,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Sept.  26, 2025  (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neuro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/26/3156974/0/en/BioVie-to-Host-Live-Investor-Webinar-and-Q-A-on-Oct-8.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HST","BK4181","BK4588","BK4585","BK4139","BIVI","BK4218"],"gpt_icon":0},{"id":"2570044151","title":"BioVie Inc. Announces Date for Upcoming Virtual Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2570044151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570044151?lang=en_us&edition=fundamental","pubTime":"2025-09-26 05:27","pubTimestamp":1758835660,"startTime":"0","endTime":"0","summary":"BioVie Inc. has scheduled its Annual Meeting of Stockholders to be held virtually on June 12, 2025. During the meeting, shareholders will vote on the election of six directors to serve until the next annual meeting and the ratification of EisnerAmper LLP as the company's independent registered public accounting firm for the fiscal year ending June 30, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL2JS6Ht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2559493859","title":"BioVie Inc. Reports Net Loss of $17.5 Million for Fiscal Year Ending June 30, 2025; R&D Expenses Drop by $13.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559493859","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559493859?lang=en_us&edition=fundamental","pubTime":"2025-08-16 05:06","pubTimestamp":1755291976,"startTime":"0","endTime":"0","summary":"BioVie Inc., a clinical-stage company focused on developing drug therapies for neurological and neurodegenerative disorders and advanced liver disease, has released its financial results for the fiscal year ending June 30, 2025. The company reported a net loss of approximately $17.5 million and net cash used in operating activities amounting to $19.0 million for the year. To date, BioVie Inc. has not generated any revenues, and no revenues are anticipated in the foreseeable future. The company emphasized the importance of securing additional capital to sustain its operations, with potential future funding sources including sales of equity, obtaining loans, or engaging in other strategic transactions. However, there is significant uncertainty regarding the company's ability to acquire sufficient financing on acceptable terms, which raises substantial doubt about its ability to continue as a going concern. BioVie Inc. continues to pursue its strategic plans, focusing on the development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL6Dw7wH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2559989266","title":"Cuong V Do, President & CEO of BioVie Inc., Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989266","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989266?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:06","pubTimestamp":1755115602,"startTime":"0","endTime":"0","summary":"Cuong V. Do, President & CEO of BioVie Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL67fcJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"gpt_icon":0},{"id":"2559816939","title":"BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2559816939","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559816939?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:05","pubTimestamp":1755115500,"startTime":"0","endTime":"0","summary":"ADDRESS-LC trial is now enrolling patients with Long COVID-related fatigue and cognitive impairment at sites across the U.S.CARSON CITY, Nev., Aug.  13, 2025  (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132962/0/en/BioVie-Highlighted-ADDRESS-LC-Phase-2-Trial-Design-Exploring-Bezisterim-for-the-Treatment-of-Neurological-Symptoms-of-Long-COVID-at-Keystone-Symposia-on-Long-COVID-and-Other-Post-A.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MT","DOD","BK4023","IE00B29SXK94.USD","BK4585","LU1169589451.USD","POST","BK4212","BK4166","BK4588","BK4006","PD","BK4139","AD","BIVI","BK4561","IE00B29SXL02.USD","LC","LU1169590202.USD"],"gpt_icon":0},{"id":"2558698301","title":"BioVie Inc. Announces Closing of $12 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2558698301","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558698301?lang=en_us&edition=fundamental","pubTime":"2025-08-12 04:05","pubTimestamp":1754942700,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Aug.  11, 2025  (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/11/3131256/0/en/BioVie-Inc-Announces-Closing-of-12-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1169590202.USD","LU1169589451.USD","LC","BIVI","PD","BK4166","BK4139","BK4023","BK4585"],"gpt_icon":0},{"id":"2557590241","title":"BRIEF-Biovie Announces Pricing Of $12 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2557590241","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557590241?lang=en_us&edition=fundamental","pubTime":"2025-08-08 08:43","pubTimestamp":1754613835,"startTime":"0","endTime":"0","summary":"BRIEF-Biovie Announces Pricing Of $12 Million Public OfferingAug 7 (Reuters) - BioVie Inc BIVI.O:BIOVIE INC. ANNOUNCES PRICING OF $12 MILLION PUBLIC OFFERINGBIOVIE INC - UNITS SOLD AT $2.00 EACH, PRE-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nTUA2K8YPJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2557590247","title":"BioVie Inc - Units Sold at $2.00 Each, Pre-Funded Units Less $0.0001","url":"https://stock-news.laohu8.com/highlight/detail?id=2557590247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557590247?lang=en_us&edition=fundamental","pubTime":"2025-08-08 08:43","pubTimestamp":1754613790,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nTUA2K8YPJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIVI"],"gpt_icon":0},{"id":"2557189605","title":"BioVie Inc. Announces Pricing of $12 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2557189605","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557189605?lang=en_us&edition=fundamental","pubTime":"2025-08-08 08:43","pubTimestamp":1754613780,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., Aug.  07, 2025  (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/08/3129900/0/en/BioVie-Inc-Announces-Pricing-of-12-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4166","LC","LU1169590202.USD","BK4585","BK4588","PD","BK4139","LU1169589451.USD","BK4023"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}